Hypha Labs (FUNI) Liabilities from Discontinued Operations (2022 - 2023)

Hypha Labs (FUNI) reported Liabilities from Discontinued Operations of 308532.0 for Q4 2023, up 93.86% quarter-over-quarter from 159156.0 in Q3 2023.

Hypha Labs (FUNI) Liabilities from Discontinued Operations (2022 - 2023) Analysis & Trends

Hypha Labs has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at 308532.0 in Q4 2023.

For the quarter ending Q4 2023, Liabilities from Discontinued Operations changed N/A year-over-year to 308532.0; the trailing twelve-month figure through Dec 2023 stood at 308532.0 (changed N/A YoY), and the FY2023 full-year result was 159156.0, down 48.7% from the prior year.
Liabilities from Discontinued Operations for Q4 2023 stood at 308532.0, up from 159156.0 in the prior quarter.
The five-year high for Liabilities from Discontinued Operations was 310253.0 in Q3 2022, with the low at 159156.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn
10	Hypha Labs	-	-	-

Download Data